-
Signature
-
/s/ Bruce Blefeld, Attorney-in-Fact
-
Stock symbol
-
ZLAB
-
Transactions as of
-
Jun 25, 2024
-
Transactions value $
-
-$133,022
-
Form type
-
4
-
Date filed
-
6/27/2024, 04:09 PM
Transactions Table
Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Ownership |
Footnotes |
transaction |
ZLAB |
American Depositary Shares |
Options Exercise |
|
+18.3K |
+35.23% |
|
70.1K |
Jun 25, 2024 |
Direct |
F1, F2, F3 |
transaction |
ZLAB |
American Depositary Shares |
Sale |
-$133K |
-7.43K |
-10.61% |
$17.90 |
62.6K |
Jun 26, 2024 |
Direct |
F1, F4 |
Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)
Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Underlying Class |
Amount |
Exercise Price |
Ownership |
Footnotes |
transaction |
ZLAB |
Restricted Share Units |
Options Exercise |
$0 |
-18.3K |
-33.33% |
$0.00 |
36.5K |
Jun 25, 2024 |
American Depositary Shares |
18.3K |
|
Direct |
F1, F3, F5 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Explanation of Responses:
Remarks:
President and Head of Global Development for Neuroscience, Autoimmune and Infectious Diseases